A relationship of baseline risk to treatment effect size has been suggested as a possible explanation of between-study heterogeneity in meta-analyses. To address this question, we develop regression models to examine the relationship between the logits (or other response measure) in the intervention
Variation in baseline risk as an explanation of heterogeneity in meta-analysis by S. D. Walter, Statistics in Medicine, 16, 2883-2900 (1997)
โ Scribed by R. M. D. Bernsen; M. J. A. Tasche; N. J. D. Nagelkerke
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 69 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
โฆ Synopsis
With many research groups in the world studying the same or similar types of intervention, there is an opportunity and a need to collate and synthesize all available evidence on the value of specific interventions. Thus, meta-analysis, the statistical science of doing this, is becoming increasingly important.
One phenomenon commonly encountered in meta-analysis is that of heterogeneity in effect. Results may differ substantially between studies; much more than could be expected on the basis of within-study parameter standard errors, the 'measurement errors'. This heterogeneity must impact on the way we analyse and interpret the data.
Often because of this heterogeneity no unequivocal conclusion on the value of the intervention can be drawn and there is a need to take study characteristics into account, so that possibly inferences from separate study groups can be made.
In a recent study, Walter, following papers by Brand and Kragt, Senn and Brand, addressed the issue of explaining heterogeneity in meta-analysis by a baseline dependent effect of the intervention.
As an explicit model he proposed the linear relationship
๐ SIMILAR VOLUMES
In a recent issue of Statistics in Medicine, Thompson, Smith and Sharp (TSS) discussed an issue that we have both separately considered in this journal before. They consider approaches through meta-analysis to examining the relationship of the efficacy of treatment to the 'underlying risk', where th